AHR and glioblastoma: On the one hand, the Trp–Kyn–AHR pathway promotes Treg cell differentiation and also upregulates PD-1 expression levels, inhibits T cell activity, and promotes immune tolerance; on the other hand, AHR is a tumor-suppressor gene in GBM, and the deletion of AHR enhances GBM tumor growth and invasion [120].